Hamilton Capital’s Agilon Health AGL Stock Holding History

Hamilton Capital’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-537	Closed	-$9.24K	–	154
2025 Q4	$9.24K	Buy	+537	New	+$10.4K	﹤0.01%	159
2025 Q2	$30.9K	Hold	537	–	–	﹤0.01%	140
2025 Q1	$58.1K	Hold	537	–	–	﹤0.01%	135
2024 Q4	$25.5K	Hold	537	–	–	﹤0.01%	129
2024 Q3	$34.2K	Hold	537	–	–	﹤0.01%	129
2024 Q2	$87.8K	Hold	537	–	–	0.01%	118
2024 Q1	$81.9K	Hold	537	–	–	0.01%	140
2023 Q4	$168K	Hold	537	–	–	0.01%	128
2023 Q3	$238K	Hold	537	–	–	0.02%	98
2023 Q2	$233K	Hold	537	–	–	0.02%	102
2023 Q1	$319K	Sell	537 -308	-36%	-$173K	0.02%	77
2022 Q4	$341K	Hold	845	–	–	0.02%	88
2022 Q3	$495K	Hold	845	–	–	0.03%	39
2022 Q2	$461K	Sell	845 -1	-0.1%	-$506	0.03%	44
2022 Q1	$536K	Sell	846 -1,122	-57%	-$578K	0.03%	41
2021 Q4	$1.33M	Buy	+1,968	New	+$1.2M	0.1%	20

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Hamilton Capital's AGL Position: Q1 2026 in Review

Hamilton Capital sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 537 shares — an estimated $9.24K sold.

Hamilton Capital first reported a position in AGL in Q4 2021 and held it in 16 quarters. The position peaked at $1.33M in Q4 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Hamilton Capital reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
Hamilton Capital sold 537 Agilon Health shares in Q1 2026, an estimated $9.24K.
Hamilton Capital first reported a position in Agilon Health in Q4 2021 and held it in 16 quarters.
Hamilton Capital's Agilon Health position peaked at $1.33M in Q4 2021.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Hamilton Capital's 13F filing for Q1 2026, filed 15 May 2026.